TrademarkDir
FEROFIT
LIVE

Serial Number

98637807

Owner

Pharmaris Canada Inc.

Attorney

Nyall Engfield

Filing Date

Jul 8, 2024

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

FEROFIT Trademark

Serial Number: 98637807 • Registration: 8027247

FEROFIT is a trademark filed by Pharmaris Canada Inc. on July 8, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Pharmaris Canada Inc. (19 trademarks)

Surrey BC V3W8J9 , CA

Entity Type: 03

Trademark Details

Filing Date

July 8, 2024

Registration Date

November 18, 2025

Published for Opposition

September 30, 2025

Goods & Services

Dietary supplements consisting primarily of iron; Dietary supplements consisting primarily of iron; Dietary supplements for supporting iron levels and to treat iron-deficiency anemia;; Food supplements for supporting iron levels and to treat iron-deficiency anemia;; Nutritional supplements consisting primarily of iron; Nutritional supplements consisting primarily of iron; Nutritional supplements for supporting iron levels and to treat iron-deficiency anemia

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 18, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 18, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 30, 2025 NPUB
PUBLISHED FOR OPPOSITION
Sep 30, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 24, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 2, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 2, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 2, 2025 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Aug 30, 2025 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jun 26, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
Jun 26, 2025 GNSL
SUSPENSION LETTER WRITTEN
Jun 26, 2025 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
May 23, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 23, 2025 CRFA
ASSIGNED TO LIE
May 23, 2025 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
May 13, 2025 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
May 7, 2025 GNS2
INQUIRY TO SUSPENSION E-MAILED
May 7, 2025 GNSI
SUSPENSION INQUIRY WRITTEN
May 7, 2025 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Mar 27, 2025 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Aug 31, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Aug 31, 2024 GNSL
SUSPENSION LETTER WRITTEN
Aug 31, 2024 CNSL
ASSIGNED TO EXAMINER
Aug 30, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 8, 2024 NWOS
NEW APPLICATION ENTERED
Jul 8, 2024 NWAP

Related Trademarks

More from this Owner

PHARMARIS IROSORB

PHARMARIS IROSORB

PHARMARIS I-MAX logo

PHARMARIS I-MAX

PHARMARIS IRONSOM FORTE

PHARMARIS IRONSOM FORTE

PHARMARIS IRONSOM FORTE

PHARMARIS IRONSOM FORTE

PHARMARIS I-MAX THERAPEUTIC 150

PHARMARIS I-MAX THERAPEUTIC 150

PHARMARIS IROSORB

PHARMARIS IROSORB